Alimera Sciences (ALIM) Earnings Date, Estimates & Call Transcripts

$5.54

0.00 (0.00%)

(As of 09/16/2024)

Upcoming Earnings Date: Oct. 24Estimated
Actual EPS (Aug. 6): -$0.06 Missed By -$0.02
Consensus EPS (Aug. 6): -$0.04

ALIM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALIM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Angel Publishing

What Is the $7,882 Stimulus Payment 2024?

Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.

Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here.

Alimera Sciences Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	1	$0.07	$0.07	$0.07
Q2 2024	1	($0.03)	($0.03)	($0.03)
Q3 2024	1	($0.01)	($0.01)	($0.01)
Q4 2024	1	$0.03	$0.03	$0.03
FY 2024	4	$0.06	$0.06	$0.06
Q1 2025	1	($0.01)	($0.01)	($0.01)
Q2 2025	1	$0.04	$0.04	$0.04
Q3 2025	1	$0.05	$0.05	$0.05
Q4 2025	1	$0.14	$0.14	$0.14
FY 2025	4	$0.22	$0.22		$0.22

ALIM Earnings Date and Information

Alimera Sciences last announced its quarterly earnings data on August 6th, 2024. The biopharmaceutical company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The business earned $27 million during the quarter, compared to analysts' expectations of $25.76 million. Alimera Sciences has generated ($1.57) earnings per share over the last year (($1.57) diluted earnings per share). Earnings for Alimera Sciences are expected to grow in the coming year, from ($0.13) to $0.21 per share. Alimera Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off prior year's report dates.

Alimera Sciences Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/24/2024 (Estimated)	-	-	-	-	-	-	-
8/6/2024	Q2 2024	($0.04)	($0.06)	($0.02)	($0.06)	$25.76 million	$27.00 million
5/14/2024	Q1 2024	($0.04)	($0.12)	($0.08)	($0.12)	$23.72 million	$23.01 million
3/7/2024	Q4 2023	$0.02	($0.07)	($0.09)	($0.07)	$25.10 million	$26.31 million
10/26/2023	Q3 2023	($0.41)	($0.06)	+$0.35	($0.06)	$24.40 million	$23.36 million
8/10/2023	Q2 2023	$0.06	($0.44)	($0.50)	$0.44	$20.36 million	$17.54 million
5/15/2023	Q1 2023	($0.58)	($0.71)	($0.13)	($0.71)	$13.00 million	$13.55 million
Get the Latest News and Ratings for ALIM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alimera Sciences and its competitors with MarketBeat's FREE daily newsletter.
3/31/2023	Q4 2022	($0.28)	($0.54)	($0.26)	($0.54)	$15.80 million	$14.03 million
11/14/2022	Q3 2022	($0.37)	($0.75)	($0.38)	($0.75)	$15.60 million	$13.60 million
7/27/2022	Q2 2022	($0.61)	($0.45)	+$0.16	($0.45)	$13.50 million	$14.60 million
5/9/2022	Q1 2022	($0.67)	($0.85)	($0.18)	($0.85)	$13.00 million	$11.90 million
2/24/2022	Q4 2021	($0.38)	($0.59)	($0.21)	($0.59)	$14.00 million	$13.96 million
10/27/2021	Q3 2021	($0.52)	($0.60)	($0.08)	($0.60)	$12.30 million	$12.15 million
8/13/2021	Q2 2021	$1.25	$0.76	($0.49)	$0.49	$23.30 million	$21.70 million
4/27/2021	Q1 2021	($0.54)	($0.63)	($0.09)	($0.63)	$11.60 million	$11.21 million
2/23/2021	Q4 2020	($0.04)	($0.18)	($0.14)	($0.18)	$13.00 million	$13.77 million
11/2/2020	Q3 2020	($0.49)	($0.12)	+$0.37	($0.12)	$10.75 million	$12.47 million
7/29/2020	Q2 2020	($2.14)	($0.51)	+$1.63	($0.51)	$2.30 million	$10.04 million
4/29/2020	Q1 2020	($0.43)	($0.24)	+$0.19	($0.24)	$14.04 million	$14.54 million
2/26/2020	Q4 2019	($0.37)	$0.08	+$0.45	$0.08	$14.50 million	$17.35 million
10/29/2019	Q3 2019	($0.60)	($0.60)	-	($0.04)	$12.75 million	$12.85 million

Alimera Sciences Earnings - Frequently Asked Questions

When is Alimera Sciences's earnings date?: Alimera Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off last year's report dates. Learn more on ALIM's earnings history.
Did Alimera Sciences beat their earnings estimates last quarter?: In the previous quarter, Alimera Sciences (NASDAQ:ALIM) missed the analysts' consensus estimate of ($0.04) by $0.02 with a reported earnings per share (EPS) of ($0.06). Learn more on analysts' earnings estimate vs. ALIM's actual earnings.
How can I listen to Alimera Sciences's earnings conference call?: The conference call for Alimera Sciences's latest earnings report can be listened to online. Listen to Conference Call
How can I read Alimera Sciences's conference call transcript?: The conference call transcript for Alimera Sciences's latest earnings report can be read online. Read Transcript
How much revenue does Alimera Sciences generate each year?: Alimera Sciences (NASDAQ:ALIM) has a recorded annual revenue of $99.68 million.
How much profit does Alimera Sciences generate each year?: Alimera Sciences (NASDAQ:ALIM) has a recorded net income of -$20.13 million. ALIM has generated -$1.57 earnings per share over the last four quarters.
What is Alimera Sciences's EPS forecast for next year?: Alimera Sciences's earnings are expected to grow from ($0.13) per share to $0.21 per share in the next year.